Early Rebiopsy to Identify Biomarkers of Tumor Cell Survival Following EGFR, ALK, ROS1 or BRAF TKI Therapy

Clinical trial NCT03042221 · RECRUITING

Trial details

NCT number: NCT03042221
Sponsor: University of Colorado, Denver
Status: RECRUITING
Study type: OBSERVATIONAL

Non-Small Cell Carcinoma of Lung, TNM Stage 4 Non-Small Cell Lung Cancer EGFR Gene Mutation ALK Gene Mutation ROSE Cluster 1 BRAF V600E

Start date: 2016-05-10
Primary completion: 2026-11-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.